2010 Annual Report
RESEARCH
OUTREACH
ADVOCACY
3
The Hepatitis B Foundation has enjoyed one of its most
productive years despite the economic downturn. We are
pleased to report that our work has been a bright spot in
one of the toughest years.
This year we have focused our efforts on making the
greatest impact on some of the greatest unmet needs.
This includes establishing consensus recommendations
for hepatitis B screening and treatment of children who
live with this disease and for primary care providers who
lack clear guidelines.
Research results take longer, but we have impressive
and tangible results to share, too. This year, the liver
cancer biomarker that we helped to discover has been
optioned to a major diagnostics company. If all goes well,
this blood test will be available for human use within the
next couple of years.
RESEARCH
IN THE LABS
YEAR IN REVIEW
Financial Information*
(Fiscal Year 2010 ending June 30, 2010)
Sources of Funds – HBF & IHVR Combined
(Total $4,322,068)
Grants
84%
$3,649,257
Charitable
Contributions 11%
$475,492
Interest >1%
$3,157
Other 4%
$194,162
So, if this is what we can accomplish in a tough year,
it has only got to become easier! Thanks to all of you for
your continued support, donations and confidence
in our mission.
Sincerely,
Building for a Cure
HBF’s groundbreaking for the expansion
of its research facility to build nine new
labs, which includes a teaching lab,
represented a bright spot during a tough
economy. Funding for the $1.4 million
renovation project was provided in part
by the HBF and its research organization,
the Institute for Hepatitis and Virus
Research, and Univest.
Research
$2,222,270
56%
LIVING SCIENCE
• Biomarkers of liver cancer enter
advanced option development with
Abbott Diagnostics (Block et al)
• Biomarkers of liver fibrosis are good
enough to advance to testing in 15,000
people with Johns Hopkins University
in an NIH-funded study
(Mehta et al, in progress)
Uses of Funds – HBF & IHVR Combined
• New drug (alkylated porphoryn)
discovered that inactivates HBV, HCV, &
HIV without harming mammalian cells
(Guo et al, submitted 2010)
Outreach and
Education 21%
(Norton et al, Hepatology 2010)
$834,920
• Liver carcinoid drug successfully
completes Phase II human studies
(Shailubhai et al, in progress with Callisto, Inc.)
Joel D. Rosen, Esq.
Chairman of the Board
• New pathway of HBV DNA synthesis
discovered (Guo et al, Journal of Virology 2009)
• Primabody, marker of infectious disease,
• Glucovir drug enhances immune attack
validated in animal studies
against hepatitis B in woodchucks
(Chen/Romano et al, in preparation)
(Total $4,028,054)
Timothy M. Block, Ph.D.
President and Co-Founder
(New Jersey)
Public Health 4%
$188,538
Supporting
Services 5%
PA state senator Chuck McIlhinney (3rd from
$210,400
right) and PA Congressman Patrick Murphy
(2nd to right) and PA state representatives
General and
Administrative 14%
$571,926
Marguerite Quinn (center) and Kathy Watson
(right) joined HBF to lend their support at
(Cuconati et al, in progress)
• Urine DNA test for colorectal cancer and • New glucovir compound protects animals
polyps and liver cancer gets major award from Dengue disease
(Chang et al, submitted 2010)
from the Coulter Foundation (Su et al)
• Human gene products discovered that
repress hepatitis B, C and other viruses
(Guo et al, Journal of Virology 2009)
• Serum micro arrays can represent 8,000
different people on a single small “chip”
(Chen et al, in progress)
our groundbreaking ceremony at the PA
Biotechnology Center (Jan 2010). HBF manages
and co-owns the Center, which it created in
* This audited financial information includes revenue and expenses from HBF and its
research institute IHVR, but excludes the Foundation’s 50% ownership (or $6.9 million) in
the PA Biotechnology Center valued at $13.8 million as per audited statements.
• Liver cancer drug to be tested in animals
2006 to accelerate its research mission.
HBF’s research is conducted in partnership with Drexel University College of Medicine,
whose labs are located at our Biotech Center.
Hepatitis B Foundation 2010 Annual Report
Dear Friends,
“We appreciate [the HBF’s] continued
support of the Hep B community. With
the addition of a second adopted child
with hep B into our family, we obviously
are supportive of your efforts in
research and education.”
4
5
International HBV Meeting 2009
Bruce Witte Lecturer 2010
Board of Directors
Biotechnology Faculty
Chairman
William Kinney, PhD
Mohan Philip, PhD, MBA
Joel Rosen, Esq.
In a special
ceremony at the
state Capital,
PA Governor
Ed Rendell
announced new
grant awards
to support
the important work of research groups that included the
HBF and its research institute – the Institute for Hepatitis
and Virus Research (IHVR) – which is led by HBF/IHVR
president Dr. Timothy Block (far left). (June 2010)
HBF coordinates this prestigious international scientific
meeting each year that attracts hundreds of researchers from
around the world to
discuss the science
of hepatitis B and
D viruses. This
year the meeting
was held in the
beautiful Loire
Valley in France.
2009 Meeting co-chairs Dr. Camille Sureau (France) and
Dr. Stephen Locarnini (Australia) model the unique HBV ties
given by HBF at the concluding banquet dinner. (Oct. 2009)
TRAINING YOUNG SCIENTISTS
“Working as a young scientist
is a unique experience. Many
doors of opportunity have
opened for me and to others
like me in the [HBF labs]. We are
encouraged to be unafraid in
our insights, and to realize that
every new discovery comes
from both standing on the
shoulders of giants and from
pioneering new ideas.”
Anne Lamontagne, former Research
Apprentice now in graduate school.
Summer College Research
Internships provide a wonderful (and
paid) opportunity for students to work
on an independent research project with
senior scientists for a 10-week period.
Funding is provided by grants from
the PA Department of Health, Merck’s
West Point Charitable Contributions
Committee, and the Charles Sigety
Family Foundation.
The High School Enrichment
Program offers a two-week “hands-on”
experience in a professional lab for
students entering their senior year.
Interactive seminars led by leaders in the
field introduce them to careers in science,
medicine, patent law, public health and
more. This program is supported in part
by Pennsylvania EITC funds received from
Universal Health Services of Delaware
and Wal-Mart Stores, Inc.
The Apprenticeship Program is
designed for the recent college graduate who
wants to gain real-life research experience
before making a decision to pursue graduate
or medical education. They receive valuable
mentorship and encouragement to become
deeply involved in their research projects
and to participate in the intellectual world
of scientists through research rounds,
journal clubs, and special seminars.
President
Timothy Block, PhD
Vice President
W. Thomas London, MD
Treasurer
R. Donald Leedy, MBA
Secretary
Janine Witte
Dr. T. Jake Liang (left), from the National
Institutes of Health, gave the 9th Annual
Bruce Witte Lecture about “Choreographing
the Tango between Hepatitis C Virus and Cells
by Functional Genomic Screen.” The lecture
series was established by HBF co-founders
Paul and Janine Witte. (April 2010)
HBF Distinguished Scientist
Award 2010
Dr. R. Palmer Beasley (center),
accompanied by his wife and research
collaborator Dr. Lu Yu Wang, received the
Distinguished Scientist Award from HBF
president Dr. Timothy Block (left) and
Nobel Laureate Dr. Baruch Blumberg
(right) at the Crystal Ball for his seminal HBV
research conducted in Taiwan that identified
mother-to-newborn transmission and the
fatal link to primary liver cancer. He served
as Chair of the National Academies Institute
of Medicine (IOM) committee that published
in January 2010 the first IOM report on
“Hepatitis and Liver Cancer”. (April 2010)
Joan M. Block, RN, BSN
Thomas Block
Stanley Broadbent
Alan Brownstein, MPH
Sandra Budinsky
James Datin
Kimberly Jungkind, RN, MPH
Dale Kindregan
Charles Sigety, Esq.
Gurney Sloan, Esq.
Catharine Williams, MGA
Robert Zivin, PhD
Medical and Scientific Advisors
Harvey Alter, MD
Timothy Block, PhD
Baruch Blumberg, MD, PhD
Carol Brosgart, MD
Nathaniel Brown, MD
Raymond Dwek, D Phil, FRS
Lawrence Friedman, MD
Robert Gish, MD
Hie-Won L. Hann, MD
W. Thomas London, MD
William Mason, PhD
Brian McMahon, MD
Kenneth Rothstein, MD
Raymond Schinazi, PhD
Bud Tennant, DVM
Senior Research Faculty
Songming Chen, PhD
Andrea Cuconati, PhD
Surendra Dheer, PhD
Sergey Ilyin, PhD
Ramila Philip, PhD
David Ren, MD, PhD
Patrick Romano, PhD
Thomas Russell, PhD
Kunwar Shailubhai, PhD, MBA
James Thacker, PhD
Michael Xu, PhD
Adjunct Research Faculty
These Drexel U. research faculty members
work at our research center and are
supported in part by HBF/IVHR funds
Jinhong Chang, MD, PhD
Mary Ann Communale, MS
Yanming Du, PhD
Alison Evans, ScD
Haitao Guo, PhD
Ju-Tao Guo, MD
Xuanyong Lu, PhD
Anand Mehta, D.Phil
Tulin Morcol, PhD
Brad Nefsky, PhD
Pamela Norton, PhD
Allen Reitz, PhD
Ying-Hsiu Su, PhD
Executive Director
Joan M. Block, RN, BSN
Chief Business Officer
Nelson Carvalho, MBA
Director of Programs
Margaret Farley, MBA
Director of Accounting
Patti McAloon, MBA
Director of Operations/IT
Konrad Kroszner
Outreach and Public Health
Nina Baltierra
Gang Chen, MD, PhD
Chari Cohen, MPH (DrPh candidate)
Jackie Corwell
Richard Kahn, MPH
Kelly La (MPH candidate)
Loretta Molle
Lauren Nonini
Hepatitis B Foundation 2010 Annual Report
State Recognition for HBF Research
6
7
Thank you to all of the individuals and organizations that have
generously supported the Hepatitis B Foundation. We truly appreciate
everyone who has contributed to advancing our Cause for a Cure!
BENEFACTORS’ SOCIETY
$1000 – $10,000 and more
Visionary Circle
$10,000 and more
Gunst Charitable Trust
Kahn Charitable Foundation
Universal Health Services of Delaware
Global Circle
$5,000 - $9,999
Timothy and Joan Block
Joseph Potz and Pam Norton
Charles Reynolds and Katharine Holloway
Tulchin Family Foundation
Founders’ Circle
$2,500 - $4,900
Bugajewski Facility Services
CCG Metamedia
High Swartz, LLP
W. Thomas and Linda London
Research Triangle Institute
Univest
Wal-Mart Stores, Inc.
President’s Circle — $1,000 - $2,499
AIG Matching Grants Program
Amper, Politziner & Mattia, LLP
Bank of America United Way Campaign
Begley, Carlin & Mandio, LLP
Stanley and Gerri Broadbent
Faith Calhoun
Delaware Valley College
Discovery Chicago
Drexel University College of Medicine
Esterly Family of The Pittsburgh
Foundation
Fox Rothschild, LLP
Glenmede Trust Company
Matt and Anne Greene
Hawai’i Community Foundation
Grace John
R. Donald and Martha Leedy
Robert Loughery
Anand and Valerie Mehta
Microsoft Giving Campaign
Pharmabridge
Plumbline Construction
Quakertown National Bank
Joel and Nancy Rosen
Claire Signs
Bud Tennant
University City Science Center
University of the Sciences
Richard Slabinski
Brian Wigdahl
Kyan Win
Paul and Janine Witte
Worth & Company
“I would love to be able to
contribute millions if I could! Your
organization has been a huge help to
me and my family and I have taken
the B-Informed newsletter with me
to doctor’s visits to make sure he
had the most current information.”
(Maine)
HBF established this year the PA Center
for Drug Discovery (PCDD) as an innovative
program of its research institute, the Institute
for Hepatitis and Virus Research, to accelerate
the translation of biomedical discoveries into
therapies for clinical evaluation in humans.
Our PCDD program encompasses activities
to improve efficiencies in early drug discovery
research and to help integrate senior scientists
back into the workforce who have been laid-off
from companies that have downsized during
the tough economy (we call this our “Up and
Out” program which has been well-received).
B Informed Now!
Breaks the Barriers
HBF revamped its annual patient conference
into a mobile event that touched down on
both U.S. coasts in Philadelphia and Los
Angeles, with Seattle, WA slated to round
out the 2010 itinerary. The B Informed Now!
Patient Workshops on hepatitis B and liver
cancer attracted almost 200 people at each
site and offered free HBV screenings as well.
Featured keynote speakers included Drs.
Emmett Keeffe (Stanford U), Hie-Won
Hann (Thomas Jefferson U), and Kenneth
Rothstein (Drexel U). Sessions were offered
in English with headsets provided for live
translations into Chinese and Korean. Podcasts
of the workshops are now available in all three
languages on our website @ www.hepb.org.
OUTREACH
IN THE COMMUNITY
(California)
Hepatitis B
The Philadelphia Story
On June 15, 2010, HBF launched
Hep B Free Philadelphia, a public health
campaign based on the successful model
in San Francisco. Hep B Free aims to
increase screening
and vaccination rates
through a citywide
mobilization effort.
HBF’s campaign also
returns hepatitis B to
the forefront in Philadelphia, which has
been at the center of the hepatitis B story
from the very beginning.
The hepatitis B virus was discovered by
HBF’s Distinguished Scholar Dr. Baruch
Blumberg (for which he won the Nobel
Prize) at Fox Chase Cancer Center in
Philadelphia, and he invented the hepatitis
B vaccine that is now manufactured by
two companies located in the region. The
first animal discovered to be most useful
in studying hepatitis B was an infected
groundhog living at the Philadelphia Zoo.
And the only national nonprofit dedicated
to this disease, the Hepatitis B Foundation,
was established in Philadelphia as well.
Making the Rounds
HBF continues to make an impact on
clinical practice through its specialty
workshops. The pediatric HBV
workshops we convened to focus on
children has resulted in the first national
recommendations for their care and
treatment; and this year’s workshop with
leading primary care providers (PCPs)
established recommendations for hepatitis
B in busy primary care settings. All of the
HBF clinical workshops were facilitated
by HBF medical advisors Drs. Brian
McMahon and Thomas London.
A Social (Networking) Butterfly
Twitter
@hepbfoundation
HBF has entered the dawn of a new era where
technology and human connections have been
blended to create the ultimate interactive
experience — Social Media Networking. We are
joining the global conversation, so please log on to
our new social media venues to keep in touch!
Facebook:
www.facebook.com/hepbfoundation
YouTube:
www.youtube.com/hepbfoundation
Linkedin:
www.linkedin.com/companies/hepatitis-b-foundation
Hepatitis B Foundation 2010 Annual Report
CALENDAR YEAR 2009 DONATIONS
“Your website has been an
invaluable tool for my family, and
we thank you for helping us in
our treatment of the disease.”
Drug Discovery
Takes Center Stage
8
9
CALENDAR YEAR 2009 DONATIONS (continued)
Ambassadors’ Circle — $500 - $999
Amgen Foundation Matching Gifts
Victor Araya
Artemis Solutions
Chistopher and Catherine Asplen
Clement and Choi Seung Au
Bricker, Landis & Hunsberger, LLP
Bridgepoint Insurance Group
Bronx Park Assets
Alan and Patti Brownstein
Brian and Annie Buinewicz
Scott and Sandy Budinsky
Andrew and Kathy Chen
Michael Christenson
John Donahue
Enantigen Therapeutics
Alan and Irma Freedman
James Horan
Joanne Jensen
Emmet Keeffe
Dale Kindregan
Anthony Klockenbrink
Richard Chung-Wen Liu
Arline Loh
Medical Diagnostic Laboratories
James Mongold
Janice Morris
Deborah Nelson
Paul Nelson
Prodesco
Yusheng Qu
Virginia Shames
Beth Snyder
David Tolle
Elizabeth Walsh
Lindsey Wayne and Eva Hogg
John Wu and Kimberly Harper
Discovery Circle — $250 - $499
Susannah Amiteye
Baldwin Publishing
Bee Bergvall and Company
Richard Bendis
Joanne Blasenheim
Joyce Block
Boa Construction
Mary Boatner
Bucks County Community College
P. (Peter) Chiang
Paul and Chari Cohen
Steve and Janet Cohen
Bertha Conyers
CP Commercial Printing
Andy Cuconati
Joshua and Miriam Feldstein
Fox Chase Cancer Center
Jamie Fox
Robert Frey
Curt and Roseanne Friehs
Gregory Gore
Thomas Grim
Henry “Dutch” and Kim Gronendahl
Caitlyn Hoang
Peter and Judith Hoekstra
Wilson Hong
Joyce Huber
Patrick Hylton
Scott Jacobs
John Jennings
Donald and Kimberly Jungkind
Patrick and Cynthia Kelly
Martin Kimmel
Izabel Lam
Peter Lamberts
Raymond Lee
Robert Leventhal
Madison Associates
Marketri
Patrick Marra
Mercer Communications
Jean Miller
Tulin Morcol
Catherine Ng
Timothy Peissig
Thomas Quirk, Jr.
David Rolf
The Sawtooth Group
Richard Sokorai
Susan Stellini
Eric Stollnitz
Ying-Hsiu Su
Sun Microsystems Foundation
James Talamonti
Dan and Cindy Taylor
David Thompson
Sarah Williams
George and Cathleen Woods
Mary Yee
ADVOCACY
ON THE HILL
(Minnesota)
5 Million Americans
Silent No More!
HBF helped to organize the first World
Hepatitis Day Rally on May 19th in Washington,
DC with the National Viral Hepatitis Roundtable
which sponsored the event. More than 50 HBF
researchers, outreach staff and board members
traveled to the Capitol to advocate for increased
federal attention and funding for chronic hepatitis.
With more than 5 million Americans living with
hepatitis B and C, we cannot be silent anymore.
Congressman Mike Honda sounds the
alarm at the World Hepatitis Day rally.
PA Congressman Patrick Murphy stands with the HBF
at the historic World Hepatitis Day rally in Washington, DC.
Landmark IOM Report on
Hepatitis and Liver Cancer
HBF Joins Historic New
Asia Pacific Coalition
HBF is proud to have been a key
participant in the Institute of Medicine
(IOM) study that looked at the U.S.
response to chronic viral hepatitis. The
landmark IOM report on Hepatitis and
Liver Cancer concluded that, “The current
approach to the prevention and control of
chronic hepatitis B and hepatitis C is not
working” and that “inadequate resources
are being allocated” to address the needs
of 5 million affected Americans. The IOM
committee met over an 18-month period and included two HBF
scientific advisers — Drs. Harvey Alter and Brian McMahon —
and HBF director of Public Health Research Dr. Alison Evans.
HBF co-founders Timothy and Joan Block
(standing, center) were invited to present U.S. advocacy
successes at a workshop in Beijing to discuss better
policy coordination for hepatitis B in the Asia Pacific.
The workshop included leading clinicians in the region
and other international groups. Discussions revolved
around the need to identify public policy issues that
impede optimized screening and linkage to care, and
to develop practical strategies to reduce the burden
of hepatitis B. At the conclusion of the workshop the
decision was made to establish a new independent,
multi-disciplinary group — Coalition for Eradication of
Viral Hepatitis in Asia Pacific (CEVHAP) — and HBF is
proud to be a charter member.
Hepatitis B Foundation 2010 Annual Report
“Our daughter was adopted from
China and most likely infected
at birth. Your work to increase
awareness of HBV will surely lead
to more extensive research, and
—I pray—an eventual cure.
Thank you.”
11
Outreach Circle — $100 - $249
Matthew Adlai-gail
Barbara Allar
Debra Andrews
Michael and Iris Artaki
Artisans Gallery
Richard Bader
Eileen Beck
Susan Bellaire
Patricia Benham
Brant Biehn
Earl Bierman
Bob Bowman
Matt Buchwitz
Jose Mari Casas
Garrett Chang
Gang Chen
Francis and Linda Chisari
Marc and Ann Clearfield
Joe and Molli Conti
Margaret Copeland
Alioune Coulibaly
David Crane
Suzanne Crilley
James and Carol Curry
Loren Danzis
David and Doris Dowdy
Tom Drakeford
Patricia Dunn
Gregory Farkas
Eric and Elizabeth Friedman
Lawrence Friedman
Roger and Nancy Gallic
GE Foundation
Genentech Givingstation
Robert Gish
Give With Liberty Campaign
GoodSearch
Mary Goudreault
William Green
David and Cynthia Gruber
Ziying Han
Richard and Hie-Won Hann
Dorothy Harris
Carol Hart
Anne Heacock
Harry and Dorothy Hellerman
Harry Hicks
David and Debra Hines
Henry Ho
Dorothy Hopkins
David Huang
Paul and Laura Hunter
Jun Iwata
Sherry Jean
Bonnie Jung
Margaret Keenan
Alan Keim
Robert Kelley
Dan Kilcup
KT Foundation
Albert Ku
Shailesh Kulkarsh
Michael and Jan Landis
John and Barbara Leavy
Rachel Lefkowitz
Kathy Licht
Jun Luo
Scott and Daryl MacKeverican
Shing-Wen Mao
Gerard Marini
Donna Mattox
Patti McAloon
Jim McGowan
Brian McMahon
Ed Meyers
Patti Monaco
Joanne Moroney
Richard Moyer
John Nardini
Clyde and Mable Ng
John and Joann Nonini
Lauren Nonini
Eleanor Orth
Edward Peritz
Janet Perper
Pina’s Pizza of Chalfont
Prudential Foundation Matching Gifts
Joohyun Pyune
Xiangdong (David) Ren
Carol Rico
Richard and Priscilla Rosenberger
Kenneth and Maria Rothstein
Bill Royal
Russell Biotech
Tom Russell
Kathleen Russo
James Ryan
James Samuels
Ronald and Joyce Sanderson
Marlene Schaps
Lester Sdorow
Richard Senker
John and Susan Shelly
James and Erica Shrimp
Nancy Marie Sidun
CALENDAR YEAR 2009 DONATIONS (continued)
Harriet Stenzel
Herbert and Joan Stevens
Frederick Stiff
Linhui Sui
Judy Tam
Joly Tang
John Taylor
Titan Mobile Shredding
Thomas and Jessica Truong
Eva Tsai
Walter Tsou
C. Theodore Tucker
Uptowne Deli & Pizzeria
Sharon Victor
Kathleen Watson
Michael Wehner
Wells Fargo Community Support
Campaign
Dietmar and Mary Lou Weselin
Deborah Wexler
Thomas Wight
Nicholas and Monica Winter
Stephen Wong
Ben Woods
Alan Chung-I Yu
Greg Zappin
Edward Zekas
Mingyu Zhu
Awareness Circle — Up to $99
Ishola Adeyemo
Steve Alexander
Danna Arnold
Earlene Austin
Bank of America Matching Gifts
Laurie Beckert
Jackie Benson
Priscilla Bizer
Geraldine Block
Paul Burton
Joyce Cain
Su Cartmell
Everett and Diana Chambers
Daniel Champagne
Ka-Ming Chan
Yeuk “Atom” Chan
Joseph Chan
Chun Chang
Henry Chuang
Robert Cohen
Anthony Colella
Joan Copp
Lorie Corley
Kathy Crissey
Brian Dang
Raymond D’Auria
R. Kimber and Christine David
Angelo DeMeo
Massimo and Mariachristina Di Blasio
Se Jong Ding
Paul Dominguez
William and Patricia Donaldson
John and Sandra Draus
Diane Ellis-Marseglia
Employment & Community Options
Linda Essary
John Estok
Rich and Terri Ferraro
Kenneth and Anne Fields
Edward Fischer
Frank and Glenna Follmer
Brian Free
Thomas Freeman
Susan Gabai
Kathleen Garcia
Inge Green
Cindy Gutowski
Richard and Renee Haliburton
Eric and Elizabeth Cohen Hamblet
Glenn Hammond
Hunt Hawkins
Marc Helman
Hollenbach Family
Max Holt
Alfred and Evelyn How
Becky Hubbell
Kevin Hull
Steven and Jo Ann Hurley
Sam Hurwitz
Suzanne Jeakle
JP Morgan Chase Employee Giving
Barry and Yoli Kahn
Nina Katz
Kathleen Kerrigan
Barbara Kilgallon
Fawn King
Sherrin Krueger
Denise Kunkel
Robert and Cheryl Lagay
Linda Landy
Bruce and Eva Marie Lauer
James and Hope Leahey
Christopher and June Leavy
King Liang
Michael and Donna Line
Erica Litschi
Frank Liu
Lan Liu
Mei Mei Ma
Thomas and Lori Macisaac
Jeffrey Markowitz
Tulaga Masaniai
Candice Vargas McAuliffe
Don McGee
Patrick and Maureen Cronin-McLaughlin
Reggie and Neema Chong Michaud
Robert Mickle, Jr.
Caroline Minnerick
Edith Mock
Carlo Momo
Leslie Moore
Morgan Stanley
Louis Muzekari
Ulviyya Nasibova
Network for Good
Thuan Nguyen
Peter Nguyen
Mark Obermann
John Oldani
Shannon O’Neill
Tsung Hsi Oulee
Mike and Meg Ovitt
St. Thomas Parish
Pfizer United Way Campaign
Rose Poponi
Kristine Powell
David Provenzano
Michelle Pugh
John and Sandra Quirinale
Bob and Jackie Radenbaugh
Wen X. Zeng Raiti
Florence Render
Charles and Lorie Roth
Matthew Schneider
Larry Schneiderman
Dennis Schuster
Yeh-Heng Sheng
Robert and Mary Sheppard
Robert Shore
Sara Shupe
I. Earl and Janet Nancy Simon
Priscilla Smith
Terry Spencer
Lauren Sproull
Denise Stern
Jeanne Stern
Christian Stranutu
Terry Strickland, II
Janet Tangney
Andy Tien
Nancy Tolle
Harry Tse and Zinna Lee
Hin Wing Tse
Heng Fu Tseng
United Way California Capital Region
Employees Campaign
Ron Uroda
Deb Watkins
Carrie Welch
Vanessa Wenzell
Lt. Roy Williams
Catherine Wolfe
Robert Woo
Lixun Zhang
Zhong Zheng
Amy Zipp
CORPORATE AND FOUNDATION
GRANTS
AAPCHO
Bayer
Bristol-Myers Squibb
Gilead Sciences
GlaxoSmithKline
Idenix
Johnson & Johnson
Merck & Co.
Merck West Point Charitable
Contributions Committee
Novartis
Onyx
Vertex Pharmaceuticals
FEDERAL AND STATE GRANTS
National Institutes of Health
Pennsylvania Department of Health
We apologize for any errors or omissions in the
donor list despite our best efforts to be as accurate
as possible. Please contact editor@hepb.org or
call 215-489-4900 so that we can print corrections
in our next newsletter. Thank you.
Hepatitis B Foundation 2010 Annual Report
CALENDAR YEAR 2009 DONATIONS (continued)
RESEARCH, Education and Advocacy IS THE KEY
Hepatitis B is an enormous global health problem.
• 2 billion people worldwide have been infected by hepatitis B. (1 out of every 3)
• 1 million people in the world die from hepatitis B each year.
Hepatitis B causes 80% of primary liver cancer worldwide.
• Liver cancer is the 3rd leading cause of death in the world.
• In the U.S., liver cancer rates are increasing as most other types of cancer are decreasing.
• The hepatitis B vaccine is the 1st anti-cancer vaccine — by preventing a hepatitis B infection.
There is no known cure for more than 400 million people worldwide
living with hepatitis B.
• Hepatitis B is preventable and treatable — now let’s make it curable!
Learn more about hepatitis B and the important work of the
Hepatitis B Foundation by visiting www.hepb.org.